SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-030714
Filing Date
2024-10-04
Accepted
2024-10-04 16:19:02
Documents
1
Period of Report
2024-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 - DK 10.04.24 rdgdoc.html 4  
1 FORM 4 - DK 10.04.24 rdgdoc.xml 4 3993
  Complete submission text file 0001437749-24-030714.txt   5473
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Issuer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 29125 W FIELD PARKWAY SUITE 235 DEER PARK IL 60010
Business Address
Krempa David (Reporting) CIK: 0001968254 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38738 | Film No.: 241355139